Posted inState Government Bipartisan bill addressing prescription drug price transparency goes to Gov. Walz by Peter Callaghan 05/10/202002/06/2024
Posted inSecond Opinion Four new opioid reports and studies reveal how serious the crisis is — and how it got that way by Susan Perry 03/08/201802/06/2024
Posted inPolitics & Policy What a boring-sounding award reveals about the creative lengths to which lobbyists will go to influence members of Congress by Sam Brodey 02/22/2018
Posted inSecond Opinion Gifts — big and small — from drug companies influence how doctors prescribe, study finds by Susan Perry 10/31/201710/31/2017
Posted inSecond Opinion ‘Low T’ television ads linked to increased testosterone use by Susan Perry 03/23/201703/23/2017
Posted inSecond Opinion Cancer drug offers a cautionary tale of the dangers of loosening FDA regulations by Susan Perry 02/07/201702/07/2017
Posted inSecond Opinion Medicine’s ‘biggest secret’: number-needed-to-treat by Susan Perry 12/15/201612/16/2016
Posted inSecond Opinion Not everyone is lauding the passage of the 21st Century Cures Act by Susan Perry 12/08/201612/08/2016
Posted inSecond Opinion How ‘premenstrual dysphoric disorder’ was defined and marketed by drug makers by Susan Perry 11/17/201611/17/2016
Posted inSecond Opinion How the pharmaceutical industry created, defined and marketed ‘overactive bladder disorder’ by Susan Perry 10/19/201610/19/2016
Posted inSecond Opinion Free meals from drug companies linked to doctors’ prescribing habits, study finds by Susan Perry 06/21/201606/21/2016
Posted inSecond Opinion The medicalization of America: how it’s making most of us ‘sick’ by Susan Perry 05/23/201605/23/2016
Posted inSecond Opinion Huge hikes in drug prices are particularly devastating for poor, disadvantaged people, say U of M doctors by Susan Perry 05/19/201605/19/2016
Posted inSecond Opinion New patient-advocacy group ‘outed’ by Minnesota-based website as ‘Astroturf’ campaign by Susan Perry 02/16/201602/17/2016
Posted inSecond Opinion How ‘outcome switching’ can fool us into thinking certain drugs are effective by Susan Perry 01/05/201601/05/2016
Posted inSecond Opinion Industry-funded doctor education courses on testosterone drugs downplay health risks, report finds by Susan Perry 10/19/2015
Posted inSecond Opinion Speed and ease with which new drugs receive FDA approval have many experts concerned by Susan Perry 09/21/201509/21/2015
Posted inSecond Opinion Re-examination of Paxil study underscores concerns about company-sponsored clinical trials by Susan Perry 09/18/201501/05/2016
Posted inSecond Opinion Newest blood-thinning drugs are the subject of a troubling, in-depth series on their safety by Susan Perry 08/06/201508/06/2015
Posted inSecond Opinion Why Congress’ bill increasing the National Institutes of Health budget might actually be bad for patients by Susan Perry 08/05/201508/05/2015